Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-007295

Senior VP - Drug Discovery gave up 22,431 shares (to pay taxes)

  • Senior VP - Drug Discovery acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Babu Yarlagadda S · Senior VP - Drug Discovery

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-19 Exercise or conversion : show line 1 in the form +50,000 $4.15 $207,500 205,587 D
2021-02-19 Shares withheld for taxes : show line 2 in the form −22,431 $11.53 $258,629 183,156 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-19 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −50,000 0 D
Loading xslF345X03/form4.xml…